Phoenix PharmaLabs Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Phoenix PharmaLabs General Information
Description
Developer of pain therapy drugs designed to treat pain and opiate addiction. The company specializes in the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction, enabling healthcare professionals to treat addiction in an effective manner.
Contact Information
Website
www.phoenixpharmalabs.comCorporate Office
- 709 North 400 West
- Suite 3 North
- Salt Lake City, UT 84054
- United States
Corporate Office
- 709 North 400 West
- Suite 3 North
- Salt Lake City, UT 84054
- United States
Phoenix PharmaLabs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 12. Grant | 15-May-2023 | Completed | Pre-Clinical Trials | |||
| 11. Seed Round | 06-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 10. Grant | 06-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 30-Sep-2022 | Completed | Pre-Clinical Trials | |||
| 8. Seed Round | 25-Jun-2021 | Completed | Startup | |||
| 7. Equity Crowdfunding | 18-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 6. Angel (individual) | Completed | Pre-Clinical Trials | ||||
| 5. Equity Crowdfunding | 08-Apr-2019 | $1.1M | $1.37M | Completed | Pre-Clinical Trials | |
| 4. Grant | 01-Jan-2018 | $2.89M | $270K | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Phoenix PharmaLabs Comparisons
Industry
Financing
Details
Phoenix PharmaLabs Competitors (5)
One of Phoenix PharmaLabs’s 5 competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Neurotez | Private Equity-Backed | Jersey City, NJ | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Collegium Pharmaceutical | Formerly VC-backed | Stoughton, MA | ||||
| Vicore Pharma Holding | Formerly VC-backed | Stockholm, Sweden |
Phoenix PharmaLabs Patents
Phoenix PharmaLabs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200276186-A1 | Use of morphinans for treating cocaine addiction, pruritis, and seizure disorders | Inactive | 20-Nov-2017 | ||
| WO-2019100057-A1 | Use of morphinans for treating cocaine addiction, pruritis, and seizure disorders | Inactive | 20-Nov-2017 | ||
| WO-2014031403-A1 | Use of morphine analogs for animal health | Inactive | 22-Aug-2012 | ||
| US-8987293-B2 | Morphinans useful as analgesics | Active | 23-Dec-2010 | ||
| ES-2604931-T3 | New morphinans useful as analgesics | Active | 23-Dec-2010 | C07D221/28 |
Phoenix PharmaLabs Signals
Phoenix PharmaLabs Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| Central Texas Angel Network | Angel Group | Minority | ||
| Netcapital | Accelerator/Incubator | Minority | ||
| United States Department of War | Government | |||
| National Institute on Drug Abuse (NIDA) | Government |
Phoenix PharmaLabs FAQs
-
When was Phoenix PharmaLabs founded?
Phoenix PharmaLabs was founded in 2002.
-
Where is Phoenix PharmaLabs headquartered?
Phoenix PharmaLabs is headquartered in Salt Lake City, UT.
-
What is the size of Phoenix PharmaLabs?
Phoenix PharmaLabs has 8 total employees.
-
What industry is Phoenix PharmaLabs in?
Phoenix PharmaLabs’s primary industry is Drug Discovery.
-
Is Phoenix PharmaLabs a private or public company?
Phoenix PharmaLabs is a Private company.
-
What is Phoenix PharmaLabs’s current revenue?
The current revenue for Phoenix PharmaLabs is .
-
How much funding has Phoenix PharmaLabs raised over time?
Phoenix PharmaLabs has raised $8.07M.
-
Who are Phoenix PharmaLabs’s investors?
National Institutes of Health, Central Texas Angel Network, Netcapital, United States Department of War, and National Institute on Drug Abuse (NIDA) are 5 of 6 investors who have invested in Phoenix PharmaLabs.
-
Who are Phoenix PharmaLabs’s competitors?
Centrexion Therapeutics, Neurotez, Ability Pharma, Collegium Pharmaceutical, and Vicore Pharma Holding are competitors of Phoenix PharmaLabs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process